We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MATX icon
7926
PUT
Matsons
MATX
$6.18B
$524K ﹤0.01%
9,200
+4,200
+84% +$229K
NKTR icon
7927
Nektar Therapeutics
NKTR
$2.58B
$524K ﹤0.01%
2,054
-17,286
-89% -$4.47M
SDG icon
7928
iShares MSCI Global Sustainable Development Goals ETF
SDG
$175M
$524K ﹤0.01%
+5,619
New +$482K
UUUU icon
7929
PUT
Energy Fuels
UUUU
$3.53B
$524K ﹤0.01%
122,900
-13,900
-10% -$31.3K
TPTX
7930
PUT
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$524K ﹤0.01%
4,300
+1,500
+54% +$164K
FRTA
7931
DELISTED
Forterra, Inc
FRTA
$524K ﹤0.01%
30,433
-496,400
-94% -$7.95M
MSA icon
7932
CALL
Mine Safety
MSA
$7.49B
$523K ﹤0.01%
3,500
+1,600
+84% +$231K
MUFG icon
7933
Mitsubishi UFJ Financial
MUFG
$254B
$523K ﹤0.01%
+117,958
New +$501K
SVC
7934
PUT
Service Properties Trust
SVC
$1.07B
$523K ﹤0.01%
9,100
+140
+2% +$7.11K
TX icon
7935
PUT
Ternium
TX
$10.6B
$523K ﹤0.01%
18,000
-4,400
-20% -$108K
RADI
7936
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
$523K ﹤0.01%
+40,746
New +$398K
PRVB
7937
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$523K ﹤0.01%
30,895
-31,179
-50% -$467K
CATC
7938
DELISTED
CAMBRIDGE BANCORP
CATC
$522K ﹤0.01%
+7,489
New +$500K
EGOV
7939
CALL
DELISTED
NIC Inc
EGOV
$522K ﹤0.01%
+20,200
New +$469K
BCYC
7940
Bicycle Therapeutics
BCYC
$292M
$521K ﹤0.01%
+29,035
New +$561K
EUFN icon
7941
PUT
iShares MSCI Europe Financials ETF
EUFN
$4.3B
$521K ﹤0.01%
29,700
-7,700
-21% -$122K
PBYI icon
7942
CALL
Puma Biotechnology
PBYI
$454M
$521K ﹤0.01%
50,800
+21,700
+75% +$220K
PFG icon
7943
PUT
Principal Financial Group
PFG
$24.3B
$521K ﹤0.01%
10,500
-8,100
-44% -$371K
PREF icon
7944
Principal Spectrum Preferred Securities Active ETF
PREF
$1.78B
$521K ﹤0.01%
+25,179
New +$512K
PROF
7945
CALL
Profound Medical
PROF
$269M
$520K ﹤0.01%
+25,300
New +$465K
TMX
7946
PUT
DELISTED
Terminix Global Holdings, Inc.
TMX
$520K ﹤0.01%
10,200
-15,400
-60% -$743K
HTT
7947
CALL
High Templar Tech Ltd
HTT
$391M
$519K ﹤0.01%
376,400
-56,500
-13% -$77.1K
OTRAU
7948
DELISTED
OTR Acquisition Corp. Unit
OTRAU
$519K ﹤0.01%
+49,501
New +$505K
L icon
7949
Loews
L
$23.6B
$517K ﹤0.01%
11,481
-44,702
-80% -$1.8M
BR icon
7950
Broadridge
BR
$19B
$516K ﹤0.01%
3,368
-112,347
-97% -$16.3M

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.